Francesca Montanari

Dr. Francesca Montanari is an Assistant Professor of Clinical Hematology at Yale School of Medicine and practices at Smilow Cancer Center in Greenwich. She specializes in treating blood diseases and cancers, particularly lymphomas. Her academic roles include membership in the Multidisciplinary T Cell Lymphoma Program and Lymphoma DART at Yale Cancer Center. She holds leadership positions in clinical trials and professional organizations like the Lymphoma Research Foundation.

Education:

• MD, University of Pavia (2002, magna cum laude)
• Postdoctoral Fellowships: Herbert Irving Cancer Center (Columbia University) and Perlmutter Cancer Center (NYU)
• Residency & Fellowship: New York University School of Medicine

Research Interests: Focuses on rare lymphoma subtypes, prognostication, and subtype-specific therapies leveraging epigenetics, biomarkers, and novel agents. Active in clinical trials evaluating combinations like azacitidine/romidepsin and PD-1 blockade with epigenetic therapies.

Clinical Trials Leadership: Principal investigator and co-investigator in multiple trials targeting T-cell lymphomas. Notable trials include a phase II study on oral azacytidine/romidepsin and a randomized trial of brentuximab vedotin/bendamustine in Hodgkin lymphoma.

Awards & Grants: No specific awards listed, but active in securing grants through Yale Cancer Center and collaborative institutions.

Labs/Teams: Engaged in the Center for Lymphoid Malignancies (Columbia University) and the Lymphoma DART program at Yale, focusing on translational research and patient care integration.